patented technology to grow and expand adult Stem Cells
Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place
Message: NEWS
| PLRS: Enters Collaboration wtih the BCRT at Charite- University Medicine Berlin | |||
| |||
| Ridgeland, MS, JUL 09, 2007 (EventX/Knobias.com via COMTEX) -- By Jay Everitt, jeveritt@knobias.com | |||
| Pluristem Life Systems, Inc. (PLRS) announced that it has entered into a Collaborative Research Agreement with the Berlin-Brandenburg Center for Regenerative Therapy (BCRT) at Charite - University Medicine Berlin. | |||
| Pluristem and BCRT will collaborate on a variety of indications utilizing mesenchymal stem cells (MSCs) derived from the placenta that have been expanded in the Company's proprietary PluriX(TM) 3-D bioreactor. The initial focus of the collaboration will be on neurological indications such as Multiple Sclerosis and Parkinson's disease. The agreement also covers organ transplantation and cardiovascular indications such as inflammatory cardiomyopathy. Pluristem will be the exclusive owner of the technology and any products stemming from the collaboration. | |||
| Professor Hans Dieter Volk, MD, Director/ Chairman of BCRT at Charite commented, "The collaboration of BCRT, working with Pluristem and their proprietary PLX cells offers several exciting prospects. We believe Pluristem's cells can potentially result in beneficial therapies for a number of diseases." | |||
| KNOBIAS DISCLAIMER: All statements made in this article were made by the Company and do not in any way reflect the opinions of Knobias. Knobias is not a registered broker-dealer, nor investment advisor, and does not endorse or recommend any securities mentioned. This story is provided for informational purposes only and is not intended for trading purposes. Knobias shall not be liable for any actions taken in reliance of any information provided herein. Republication or redistribution of Knobias content is expressly prohibited without prior written consent of Knobias.com, LLC. | |||
| ABOUT KNOBIAS: Knobias is a premier financial information provider of trading and investing data covering all U.S. equities for investors and security professionals. Knobias is best described by its three major components: Real-time desktop applications providing quotes, charts, level 2, analysis etc.; Knobias RAiDAR providing thousands of real-time news stories, alerts and documents daily; Knobias fundamentals providing a comprehensive database of fundamental research information. | |||
| If your company wishes to participate in the EventX newswire, please contact Knobias: http://www.knobias.com | |||
| |||
| Copyright 2004 Knobias.com, LLC, All rights reserved. | |||
New Message
Please
login
to post a reply